Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Novel 1H-Indole-3-carboxamide Derivatives as CDK4 Inhibitors for Treating Cancer.

Created on 20 Aug 2026

Authors

Ram W Sabnis

Published in

ACS medicinal chemistry letters. Volume 17. Issue 8. Pages 1731-1733. Aug 13, 2026. Epub Jul 31, 2026.

Abstract

Provided herein are novel 1H-indole-3-carboxamide derivatives as CDK4 inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.

PMID:
42622022
Bibliographic data and abstract were imported from PubMed on 20 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement